30 May 2016

PAI Partners ("PAI") have entered into an agreement to acquire Atos Medical (the "Company") from EQT VI. Atos Medical is a fast-growing medical device company holding an undisputed global leadership position within the laryngectomy market.

Atos Medical develops, manufactures and sells a range of products that help patients who have undergone total laryngectomy to restore their ability to speak and increase their quality of life. Operating under a proven chronic care business model, which provides high and robust revenue predictability, the Company has delivered strong profitable growth and an excellent financial track record over the last decades as it has developed the market for its products and established a global customer base.

Ragnar Hellenius, Partner and Head of the PAI Nordic team:
“We are very proud to become the new owners of Atos Medical, a company that gives their voice back to patients who have been through invasive life-changing surgery. We are backing an outstanding management team under the leadership of Mr Claus Bjerre, who possesses unparalleled experience and capabilities in the world of chronic care. We believe the journey and transformational strategy that EQT has started together with Mr Claus Bjerre and his team is well founded and one we will continue to support.”

Claus Bjerre, CEO Atos Medical:
“We are very excited to partner with PAI Partners to continue to grow our company. PAI shares Atos’ ambition to rapidly grow our business within our highly underpenetrated core market, by investing in R&D, further developing our direct-to-consumer sales model, and expanding our global sales presence. We believe that PAI, with its industrial approach, healthcare sector capabilities, and global network, is an ideal partner for Atos to fully realise our strategy and growth ambitions.”

This acquisition will be the 10th investment by PAI Europe VI and is a testimony of PAI’s proven operating model, combining local sourcing and execution capabilities with sector expertise. It is also a further example of PAI’s long-standing commitment to the Healthcare sector.
The transaction is expected to close during the summer of 2016.